Feds bar insurer from adding new customers after it denied medicines to seniors.

Biotech firm expects its pipeline to prosper.

Government says insurer isn't giving Medicare users what they need.

Takeover gives drugmaker's new antibiotic the financing it needs if it is to make it to market.

The generic drugmaker in China lowers earnings outlook as sales shrivel.